TNL Mediagene (Nasdaq: TNMG) launches special committee for strategic options
Rhea-AI Filing Summary
TNL Mediagene reported that its Board of Directors has formed a special committee of independent directors to lead an evaluation of potential strategic transactions and alternatives. The committee consists of Priscilla Han (Chair), Lauren Zalaznick, and Naoko Okumoto.
The special committee is authorized to review, evaluate and, as appropriate, negotiate and make recommendations on options that may include a financing, recapitalization, merger, business combination, share issuance, disposition, or continuing the current operations. It has engaged Greenberg Traurig, LLP as independent legal counsel and Imperial Capital, LLC as independent financial advisor, with Imperial Capital tasked to identify and evaluate transactions aimed at maximizing shareholder value. Management will continue operating the business and support the process when requested. No definitive course of action has been determined, and there is no assurance that any transaction will occur.
Positive
- None.
Negative
- None.
Filing Explained
The August 3 Form 6-K is incorporated into TNL Mediagene’s existing F-1 registration statement unless later filings supersede it, but it reports no agreement or completed transaction; the strategic review remains exploratory.
Key Figures
Key Terms
special committee regulatory
strategic transactions and alternatives financial
recapitalization financial
business combination financial
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What strategic step did TNL Mediagene (TNMG) take in August 2026?
Who serves on TNL Mediagene (TNMG)’s special committee?
Which advisors support TNL Mediagene (TNMG)’s strategic review?
What types of strategic alternatives is TNL Mediagene (TNMG) considering?
Has TNL Mediagene (TNMG) committed to any transaction yet?
How will TNL Mediagene (TNMG)’s operations run during the strategic review?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number 001-42424
TNL Mediagene
| 23-2 Maruyamacho | 4F., No. 88, Yanchang Rd. | |
| Shibuya-ku, Tokyo 150-0044 | Xinyi District | |
| Japan | Taipei City 110 | |
| +81-(0)3-5784-6742 | Taiwan | |
| +866-2-6638-5108 |
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Explanatory Note
Formation of Special Committee, Engagement of Imperial Capital as Financial Advisor To Pursue Strategic Alternatives to Maximize Shareholder Value
On August 3, 2026, TNL Mediagene, a Cayman Islands exempted company (the “Company”) announced that its Board of Directors (the “Board”) has established a special committee of independent directors (the “Special Committee”) to evaluate and, as appropriate, negotiate and make recommendations to the Board with respect to potential strategic transactions and alternatives available to the Company.
The Special Committee has retained independent legal and financial advisors Greenberg Traurig, LLP and Imperial Capital, LLC to assist it. Imperial Capital’s mandate includes sourcing and evaluating a full range of strategic alternatives.
The Special Committee along with Imperial Capital will review and consider various alternatives in an effort to maximize shareholder value. The Company has not entered into any agreement with respect to any proposal to date and there can be no assurance that any transaction will be consummated.
A copy of the press release issued by the Company is furnished as Exhibit 99.1 to this report on Form 6-K.
This Report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-1 (File No. 333-293957), and shall be a part of such Registration Statement from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished by the Company.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TNL Mediagene. | |||
| Date: August 3, 2026 | By: | /s/ Motoko Imada | |
| Name: | Motoko Imada | ||
| Title: | Chief Executive Officer | ||
2
EXHIBIT INDEX
| Exhibit No. | Description of Exhibits | |
| 99.1 | Press Release by TNL Mediagene dated August 3, 2026 |
3
Exhibit 99.1
TNL Mediagene (Nasdaq: TNMG)
PRESS RELEASE
TNL Mediagene Establishes Special Committee to Evaluate Strategic Alternatives, Engages Imperial Capital as Financial Advisor to Pursue Strategic Alternatives to Maximize Shareholder Value
| - | TNL Mediagene’s Board of Directors has established a special committee of independent directors to evaluate, and make recommendations to the Board regarding, potential strategic transactions and alternatives available to the Company. |
| - | The special committee is composed solely of independent directors — Priscilla Han (Chair), Lauren Zalaznick, and Naoko Okumoto. |
| - | The special committee has retained Greenberg Traurig, LLP as its independent legal counsel and Imperial Capital, LLC as its independent financial advisor, each reporting solely to the special committee. |
TOKYO, JAPAN, August 3, 2026 — TNL Mediagene (Nasdaq: TNMG) (the “Company”), a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia, today announced that its Board of Directors (the “Board”) has established a special committee of independent directors (the “Special Committee”) to lead the Company’s evaluation of potential strategic transactions and alternatives.
The Special Committee is composed solely of independent directors and consists of Priscilla Han, who serves as Chair, Lauren Zalaznick, and Naoko Okumoto. The Special Committee has been authorized by the Board to review, evaluate and, as appropriate, negotiate and make recommendations to the Board with respect to potential strategic transactions and alternatives available to the Company, which may include, among others, a financing, recapitalization, merger, business combination, share issuance, disposition or other strategic transaction, as well as the alternative of continuing to pursue the Company’s existing operations. The Special Committee’s mandate is to act in the best interests of the Company and its shareholders as a whole.
To assist in its work, the Special Committee has retained Greenberg Traurig, LLP as its independent legal counsel and Imperial Capital, LLC as its independent financial advisor. Each advisor was selected and engaged by, and reports solely to, the Special Committee. Imperial Capital’s mandate is to identify and evaluate transactions that would maximize value for the Company’s shareholders.
While the Special Committee conducts its evaluation, the Company’s management will remain focused on the effective operation of the Company’s businesses. Management will support the Special Committee’s process as and when requested by the Special Committee, subject to the Special Committee’s conflicts protocol and the recusal of any interested member of management from matters in which he or she has an interest.
No definitive course of action has been determined with respect to any strategic transaction or alternative, and there can be no assurance that the Special Committee’s evaluation will result in any transaction, or as to the terms, structure or timing of any transaction that may be pursued. The Board cautions the Company’s shareholders and others considering trading in the Company’s securities that no decision has been made with respect to any transaction. The Company does not intend to disclose or comment on developments regarding the Special Committee’s evaluation unless and until it determines that further disclosure is appropriate or required.
2
About TNL Mediagene
Headquartered in Tokyo, TNL Mediagene (Nasdaq: TNMG) is a technology company providing AI-powered advertising, marketing technology, content commerce, and data analytics solutions to brands and agencies across Asia. Formed in May 2023 through the merger of Japan’s Mediagene Inc. and Taiwan’s The News Lens Co., Ltd., the Company combines advertising and marketing technology platforms with a portfolio of established digital media brands to deliver integrated solutions for the evolving digital landscape.
The Company’s technology offerings include AI-driven advertising, marketing and digital studio services, content commerce, and advanced data analytics capabilities. These solutions are supported by the Company’s well-established multi-language digital media brands in Japanese, Chinese, and English, spanning business, technology, lifestyle, and culture, which provide audience engagement and first-party data.
Known for its appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 480 employees with offices in Japan and Taiwan.
https://www.tnlmediagene.com/
For further information, please contact:
Media: PR@tnlmediagene.com
Investors: IR@tnlmediagene.com
3
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene’s future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “aim,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements about TNL Mediagene’s future business plan and growth strategies and statements by TNL Mediagene’s management. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene’s filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading “Risk Factors” in TNL Mediagene’s Annual Report on Form 20-F filed on April 30, 2026, as may be supplemented or amended by the TNL Mediagene’s Reports of a Foreign Private Issuer on Form 6-K. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.
4